← All trials
NCT04915846
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 18, 2020
- Primary completion
- Jul 31, 2023
- Completion date
- Dec 31, 2023
- First posted
- Jun 7, 2021
- Last posted
- Jun 23, 2021
- Enrollment
- 16
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- The Hospital for Sick ChildrenLead sponsor
- University of TorontoSponsor investigator
- University of TorontoOverall official - principal investigator
- Canadian Institutes of Health Research (CIHR)Collaborator
- Cures Within ReachCollaborator
- Will Cure USACollaborator
- University of LondonCollaborator
- Mogford Campbell Family Chair FundCollaborator
- The Joshua Frase Foundation USACollaborator
- Myotubular TrustCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.